Table 2—

Spearman correlations in type 1 diabetic subjects and control subjects

Type 1 diabetic subjects (n = 98)
Control subjects (n = 57)
AI (P)AI75 (P)AI (P)AI75 (P)
HbA1c0.076 (0.46)0.089 (0.39)0.060 (0.66)0.094 (0.49)
Total cholesterol0.055 (0.60)0.056 (0.59)0.150 (0.27)0.198 (0.14)
Triglycerides0.096 (0.35)0.061 (0.55)0.018 (0.89)0.046 (0.73)
HDL−0.027 (0.80)0.086 (0.41)0.192 (0.15)0.126 (0.35)
LDL0.062 (0.54)−0.013 (0.89)0.071 (0.16)0.076 (0.58)
Glucose0.164 (0.11)0.132 (0.20)0.004 (0.97)−0.0004 (0.997)
Systolic blood pressure−0.132 (0.20)−0.144 (0.15)−0.289 (0.03)−0.169 (0.21)
Diastolic blood pressure0.094 (0.36)0.094 (0.35)−0.059 (0.66)0.058 (0.67)
IL-1β−0.190 (0.06)−0.079 (0.44)0.210 (0.12)0.010 (0.46)
IL-6−0.150 (0.14)−0.126 (0.22)−0.152 (0.26)−0.074 (0.59)
hsCRP−0.005 (0.96)0.004 (0.96)0.059 (0.66)0.133 (0.33)
Family history of hypertension0.120 (0.24)0.149 (0.14)−0.114 (0.44)−0.066 (0.63)
Family history of early cardiovascular disease−0.031 (0.44)−0.078 (0.45)0.345 (0.0086)0.381 (0.0034)
Family history of elevated cholesterol−0.132 (0.20)−0.101 (0.33)0.303 (0.02)0.218 (0.10)
Exercise0.027 (0.79)0.032 (0.76)−0.346 (0.0083)−0.449 (0.0005)
Years of diabetes0.041 (0.44)0.080 (0.44)NANA
  • Bold face indicates significance.